The Beatrice Hunter Cancer Research Institute CRTP Integrated Learning Session (ILS) will be held on Wednesday 28 November from 10:00am-12:00pm ADT in room 2L7, 2nd floor, Tupper Building Link, Dalhousie University and by videoconference to the following sites:
• Dalhousie Halifax –2L3, Second Floor, Tupper Link
• Georges Dumont Hospital - Salle de vidéoconférence-Hémo 3- local 2502
• MUN – Meeting room 3 (HSC 2985)
• Dalhousie Truro –Student Learning Commons – SLC Boardroom
• CBU – B260-A
• UNB St. John – LRC 266
• Acadia – BAC144A
ILS sessions are mandatory for CRTP Trainees – please contact email@example.com if you are unable to attend. Trainees recognize the benefit of having supervisors in attendance at these sessions and we hope that all supervisors of CRTP trainees will attend as many sessions as possible.
Cannabinoids as Potential Antitumor Agents
Cristina Sanchez, PhD
Associate Professor of Biochemistry and Molecular Biology, Complutense University, Madrid, Spain
Cristina graduated in Biology at Universidad Complutense de Madrid in 1994, and obtained her PhD with Honors in 2000 at the same University. During this period, she studied the effects of cannabinoids on energy metabolism first, and cancer cell proliferation later. After a 3-year postdoctoral stay at University of California Irvine, she returned to Spain and started coordinating a research group focused in understanding and exploiting cannabinoids as potential antitumoral agents in breast cancer. She's the author of more than 50 peer-reviewed research articles, the current Secretary and one of the founding members of the Spanish Observatory on Medicinal Cannabis, a member of the Spanish Cannabinoid Research Society Board of Directors, and Vice-Dean of Research of the School of Biology at Complutense University.
PLEASE NOTE: It is important to mute mics when not in use so that background noise is minimal. For technical support during sessions, please phone: 1-855-265-7142